Compounds > ci 934
Page last updated: 2024-09-03

ci 934 and enoxacin

ci 934 has been researched along with enoxacin in 9 studies

Compound Research Comparison

Studies
(ci 934)		Trials
(ci 934)		Recent Studies (post-2010)
(ci 934)		Studies
(enoxacin)		Trials
(enoxacin)		Recent Studies (post-2010) (enoxacin)
330273474122

Protein Interaction Comparison

ProteinTaxonomyci 934 (IC50)enoxacin (IC50)
V-type proton ATPase subunit B, brain isoformHomo sapiens (human)10
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)10

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB1
Avesani, V; Delmee, M1
Berlin, OG; Bruckner, DA; Young, LS1
Habiyaremye, I; Vandepitte, J; Verbist, L1
King, A; Phillips, I; Shannon, K; Slegg, J1
Finch, R; Martin, J; Pilkington, R1
King, A; Phillips, I1
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C1
Floyd-Reising, SA; Hindler, JA; Kelley, SG; Young, LS1

Other Studies

9 other study(ies) available for ci 934 and enoxacin

ArticleYear
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1986
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines

1986
In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines

1987
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2

    Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica

1987
The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Fluoroquinolones; Nalidixic Acid; Naphthyridines; Quinolines; Staphylococcus; Streptococcus

1986
In vitro assessment of CI-934--a new quinolone derivative.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:6

    Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin

1986
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl D

    Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines

1986
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
    Diagnostic microbiology and infectious disease, 1987, Volume: 6, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Regression Analysis

1987
In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
    Diagnostic microbiology and infectious disease, 1987, Volume: 6, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Quinolines; Vancomycin

1987